These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35006020)

  • 1. Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities.
    Aslan Candır B; Yiğenoğlu TN; Kızıl Çakar M; Dal MS; Altuntaş F
    J Oncol Pharm Pract; 2022 Jun; 28(4):972-974. PubMed ID: 35006020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete resolution of chylothorax with ibrutinib in chronic lymphocytic leukemia: a case report.
    Cheng L; Huang M; Wei J; Xu H; Zhou M; Jiang L
    Ann Palliat Med; 2022 May; 11(5):1833-1837. PubMed ID: 34328006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azacitidine-induced massive pericardial effusion in a child with myelodysplastic syndrome.
    Fogaça da Mata M; Vieira Martins M; Rato J; Madeira M; Gonçalves JP; Teixeira A; Anjos R
    J Oncol Pharm Pract; 2022 Jun; 28(4):975-978. PubMed ID: 35037800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large hemorrhagic pericardial effusion with cardiac tamponade in a 16-year-old adolescent in an endemic area of tuberculosis: a case report.
    Nkoke C; Makoge C; Tewafeu D; Nkouonlack C; Njoya C; Nepetsoun I; Luchuo EB; Jingi AM
    Pan Afr Med J; 2021; 40():117. PubMed ID: 34887991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal effusion due to pericardiocentesis with cardiac tamponade: a case report.
    Zhang Q; Wang D; Liu Y
    BMC Anesthesiol; 2021 Jun; 21(1):172. PubMed ID: 34134618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report.
    Nagamori Y; Hamaoka T; Murai H; Takashima S; Kato T; Usui S; Sakata K; Furusho H; Kawashiri M; Takamura M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):67. PubMed ID: 32028901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term minoxidil use associated with pericardial effusion and cardiac tamponade: an uncommon presentation.
    Pasala KK; Gujja K; Prabhu H; Vasavada B; Konka S
    Am J Ther; 2012 Nov; 19(6):e186-8. PubMed ID: 21519225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhagic Cardiac Tamponade Associated with Apixaban: A Case Report and Systematic Review of Literature.
    Asad ZUA; Ijaz SH; Chaudhary AMD; Khan SU; Pakala A
    Cardiovasc Revasc Med; 2019 Nov; 20(11S):15-20. PubMed ID: 31088720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
    Hou JZ; Ryan K; Du S; Fang B; Marks S; Page R; Peng E; Szymanski K; Winters S; Le H
    Future Oncol; 2021 Dec; 17(35):4959-4969. PubMed ID: 34783255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete resolution of chylopericardium after chemotherapy for chronic lymphocytic leukemia.
    Morris AL; Colbourne T; Kirkpatrick I; Banerji V
    Curr Oncol; 2019 Oct; 26(5):e696-e699. PubMed ID: 31708663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericardial tamponade due to haemorrhagic pericardial effusion as a complication of prasugrel: a case report.
    Cader FA; Haq MM; Nasrin S; Karim MR
    BMC Cardiovasc Disord; 2016 Aug; 16(1):162. PubMed ID: 27577194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minoxidil-associated pericardial effusion and impending tamponade.
    Lew MJ; Amato J
    JAAPA; 2023 Dec; 36(12):21-23. PubMed ID: 37989166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Presentation of Small Lymphocytic Lymphoma with Pericardial Effusion.
    Nnaoma C; Chika-Nwosuh O; Mbonu I; Sossou CW; Okonkwo CC; Isedeh A
    Am J Case Rep; 2019 Jul; 20():1128-1131. PubMed ID: 31363076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy.
    Miatech JL; Hughes JH; McCarty DK; Stagg MP
    Case Rep Hematol; 2020; 2020():4282486. PubMed ID: 32280549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study.
    Byrd JC; Furman RR; Coutre SE; Flinn IW; Burger JA; Blum K; Sharman JP; Wierda W; Zhao W; Heerema NA; Luan Y; Liu EA; Dean JP; O'Brien S
    Clin Cancer Res; 2020 Aug; 26(15):3918-3927. PubMed ID: 32209572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis].
    Maisch B; Karatolios K; Pankuweit S
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2143-6. PubMed ID: 16991029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial.
    Sharman JP; Brander DM; Mato AR; Ghosh N; Schuster SJ; Kambhampati S; Burke JM; Lansigan F; Schreeder MT; Lunin SD; Zweibach A; Shtivelband M; Travis PM; Chandler JC; Kolibaba KS; Sportelli P; Miskin HP; Weiss MS; Flinn IW
    Lancet Haematol; 2021 Apr; 8(4):e254-e266. PubMed ID: 33631112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia.
    Kidoguchi K; Kubato Y; Nishimura Y; Kizuka-Sano H; Kimura S
    Turk J Haematol; 2021 Feb; 38(1):83-85. PubMed ID: 33161683
    [No Abstract]   [Full Text] [Related]  

  • 19. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
    Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
    Front Immunol; 2021; 12():766272. PubMed ID: 34912339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer.
    Tomkowski WZ; Filipecki S
    Lung Cancer; 1997 Mar; 16(2-3):215-22. PubMed ID: 9152952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.